| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 12 4884-4891, Copyright © 1996 by American Association of Immunologists
ARTICLES |
CJ Roberge, PE Poubelle, AD Beaulieu, D Heitz and J Gosselin
Laboratory of Viral Immunology, University of Laval, Sainte-Foy, Quebec, Canada.
The present study investigated the effect of EBV on gene expression and protein synthesis of IL-1 and its natural IL-1R antagonist (IL-1Ra) in human peripheral blood neutrophils. EBV induced a rapid accumulation of IL-1 and IL-lRa mRNA in neutrophils that was associated with the later appearance of considerable amounts of IL-1alpha, IL-1beta, and IL-Ra proteins. Approximately 3200 and 610 times more IL-Ra than IL-1alpha a or IL-1beta, respectively, was secreted by neutrophils in response to EBV. The effect induced by EBV cannot reflect an overall metabolic activity of neutrophils, since EBV failed to induce granulocyte- macrophage OF synthesis. Heat-inactivated virus was unable to stimulate cytokine synthesis, whereas UV-irradiated virus retained the full IL-1- and IL-1Ra-inducing potential of the native particle. Furthermore, pretreatment of cells with cycloheximide or phosphonoacetic acid did not abrogate the effect of EBV, suggesting that EBV does not penetrate the cell, but that a virion's structural molecule is required to induce such an effect. In this respect, neutralization of the viral particles with the mAb 72A1, which is known to react with glycoprotein gp350 of the viral envelope, inhibits the production of IL-1 and IL-1Ra, suggesting that gp350 could be involved in this process. Thus, the elevated levels of IL-1Ra detected for EBV-stimulated neutrophils might be part of a mechanism used by the virus to evade the immune system.
This article has been cited by other articles:
|
|
 |
|
  K. A. Young, X. S. Chen, V. M. Holers, and J. P. Hannan Isolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21) J. Biol. Chem., December 14, 2007; 282(50): 36614 - 36625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Urquiza, R. Lopez, H. Patino, J. E. Rosas, and M. E. Patarroyo Identification of Three gp350/220 Regions Involved in Epstein-Barr Virus Invasion of Host Cells J. Biol. Chem., October 21, 2005; 280(42): 35598 - 35605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ethuin, C. Delarche, S. Benslama, M.-A. Gougerot-Pocidalo, L. Jacob, and S. Chollet-Martin Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils J. Leukoc. Biol., September 1, 2001; 70(3): 439 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Mogensen and S. R. Paludan Molecular Pathways in Virus-Induced Cytokine Production Microbiol. Mol. Biol. Rev., March 1, 2001; 65(1): 131 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Huang, T.-S. Sheen, C.-L. Chen, J. Lu, Y. Chang, J.-Y. Chen, and C.-H. Tsai Profile of Cytokine Expression in Nasopharyngeal Carcinomas: A Distinct Expression of Interleukin 1 in Tumor and CD4+ T Cells Cancer Res., April 1, 1999; 59(7): 1599 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Larochelle, L. Flamand, P. Gourde, D. Beauchamp, and J. Gosselin Epstein-Barr Virus Infects and Induces Apoptosis in Human Neutrophils Blood, July 1, 1998; 92(1): 291 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Roberge, S. R. McColl, B. Larochelle, and J. Gosselin Granulocyte-Macrophage Colony-Stimulating Factor Enhances EBV-Induced Synthesis of Chemotactic Factors in Human Neutrophils J. Immunol., March 1, 1998; 160(5): 2442 - 2448. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
